Obesity and hyperinsulinemia have been associated with increased amounts of circulating bioactive insulin-like growth factor-I (IGF-I), a growth factor determined to play a pathogenic role in many cancers [81]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.